Tocqueville Asset Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Tocqueville Asset Management’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-11,650	Closed	-$382K	–	870
2016 Q3	$382K	Sell	11,650 -9,000	-44%	-$274K	﹤0.01%	669
2016 Q2	$516K	Sell	20,650 -900	-4%	-$24.4K	0.01%	629
2016 Q1	$528K	Buy	21,550 +14,925	+225%	+$346K	0.01%	619
2015 Q4	$219K	Sell	6,625 -15,000	-69%	-$507K	﹤0.01%	832
2015 Q3	$708K	Buy	21,625 +8,125	+60%	+$345K	0.01%	623
2015 Q2	$715K	Buy	+13,500	New	+$491K	0.01%	630

Other funds holding ALDR

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return